Caplacizumab

From WikiMD.org
Jump to navigation Jump to search
Caplacizumab
TermCaplacizumab
Short definitionCaplacizumab - (pronounced) (KAP-luh-SIH-zoo-mab) drug used in conjunction with plasma exchange and immunosuppressive therapy to treat acquired thrombotic thrombocytopenic purpura (aTTP). aTTP is a rare blood disorder in which blood clots form in small blood vessels throughout the body. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


Caplacizumab - (pronounced) (KAP-luh-SIH-zoo-mab) drug used in conjunction with plasma exchange and immunosuppressive therapy to treat acquired thrombotic thrombocytopenic purpura (aTTP). aTTP is a rare blood disorder in which blood clots form in small blood vessels throughout the body. Caplacizumab attaches to a protein called VWF, which can help prevent blood clots from forming. It's a kind of nanobody (a tiny antibody). Also called Cablivi

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski